Bendamustine Bridge to Autologous or Allogeneic Transplant for Relapsed/Refractory Lymphoma

NCT02059239 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

34

Enrollment

OTHER

Sponsor class

Conditions

Hodgkin's Lymphoma
Non-Hodgkin's Lymphoma

Interventions

DRUG: Bendamustine
DRUG: Carmustine
DRUG: Etoposide
DRUG: Melphalan
DRUG: Cytarabine
DRUG: Alemtuzumab
BIOLOGICAL: Autologous Stem Cell Transplantation
BIOLOGICAL: Allogeneic Stem Cell Transplantation
DRUG: Rituximab

Sponsor

Weill Medical College of Cornell University